Michael Wiedmann
9Patents
6h-index
15Co-inventors
52Inventor score
Filing activity: Aug 7, 1995 → Jul 7, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5863740A | Interference eliminating agent for application in immunoassays | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5804391A | Elimination of rheumatoid factor interference using anti-FD antibodies | Emerging Cross-Sectional Technologies | 22 | Expired |
| US6613530B1 | Determination of a specific immunoglobulin using multiple antigens | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6306579A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6096319A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5952185A | Photo-activatable biotin derivatives and their use to reduce interference in immunoassays | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6270960A | Recombinant antigen from the NS3 region of the hepatitis C virus | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7122302B2 | Method for determining early HCV seroconversion | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7629295B2 | Determination of a specific immunoglobulin using multiple antigens | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.